Allurion publishes new data demonstrating muscle mass preservation

Allurion Technologies announced the publication of a study in the journal Clinical Obesity on the impact of the Allurion Program on weight reduction and body composition. The study evaluated weight loss and body composition changes for 167 patients with an average body mass index BMI of 31.3. After four months of balloon therapy, patients achieved an average weight reduction of 15.7%. Patients continued to lose weight after balloon passage, with an average weight loss of 17.1% at six months. At 12 months after balloon placement, the average weight loss was 14.7%, which demonstrates a 94% weight loss maintenance eight months after passage of the balloon. Importantly, patients experienced significant reductions in body fat percentage, decreasing from 39% to 35.7% at six months, while muscle mass was preserved. No serious adverse events were reported. “This study highlights that with proper preparation and follow-up, the Allurion Balloon provides safe and effective weight loss while maintaining muscle mass,” said Dr. Napoleon Salgado Macias, the study’s senior author. “With adherence to the Allurion Program’s lifestyle changes, individuals can achieve sustainable, long-term weight maintenance and significant improvements in body composition.”